Bioeconomy Capital (now Planetary Technologies) is an early-stage venture capital firm based in Seattle, Washington, investing in biotechnology, synthetic biology, and advanced bio-manufacturing companies developing scalable biological processes to reduce global fossil fuel reliance.
89% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Their most common stage is series-a (56% of deals). Average disclosed round size is $18.6M (across 8 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
RW
Rik Wehbring
Managing Director
RC
Rob Carlson
Managing Director
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| ZZymeCo | Series A | $4M | Jul 2026 |
 Parse Biosciences | Series C | — | Dec 2023 |
| Parse Biosciences | Series C | $50M | Jan 2023 |
| Parse Biosciences | Series A | $7M | Jan 2021 |
 Synthace | Series A | $7.3M | Sep 2017 |
 Arzeda | Series A | $12M | Jul 2017 |
 Lumen Bioscience | Series B | $16M | — |
| Lumen Bioscience | Series A | $11.2M | — |
| Parse Biosciences | Series B | $41.5M | — |
Top Co-Investors
Logos Capital4 shared
Marshall Wace4 shared
Soleus Capital3 shared
Gates Foundation2 shared
Founders, Inc.2 shared
SOSV1 shared
Sofinnova Partners1 shared
Amadeus Capital Partners1 shared
Eleven Two Capital1 shared
WestRiver Group1 shared
Columbia Pacific Advisors1 shared
WRF Capital1 shared
Casdin Capital1 shared
OS Fund1 shared
British International Investment1 shared
Last updated: 20 October 2026